Medicine passport

Miragron 50 mg

The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.

Active substance
Mirabegron
Strength
50 mg
Form
prolonged - release tablets
ATC code
G04BD12
Registered in
Bulgaria · STADA Arzneimittel AG
Prescription
Prescription only
Reg. no.
20250319

Source: Bulgarian Drug Agency register · 2026-08-01

Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.

Listed in other countries

United States 9 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
Mirabegron50 mg · Tablet, Film Coated, Extended ReleasePrescription onlyLupin Pharmaceuticals, Inc. (+6)68180-152
Mirabgeorn50 mg · Tablet, Film Coated, Extended ReleasePrescription onlyQilu Pharmaceutical Co., Ltd.67184-0572
Myrbetriq50 mg · Tablet, Film Coated, Extended ReleasePrescription onlyAstellas Pharma US, Inc.0469-2602

Source: NDC Directory (US Food and Drug Administration) · 2026-09-13 · Source: US Food and Drug Administration, NDC Directory.

Spain 9 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
BAXIRTO50 mg · comprimido de liberación prolongadaPrescription onlyLaboratorios Alter S.A.90283
BETMIGA50 MG · comprimido de liberación prolongadaPrescription onlyAstellas Pharma Europe B.V.112809010
IRETIG50 mg · comprimido de liberación prolongadaPrescription onlyZentiva K.S.90043
MIRABEGRON ALTER50 mg · comprimido de liberación prolongadaPrescription onlyLaboratorios Alter S.A.90280
MIRABEGRON CINFAMED50 mg · comprimido de liberación prolongadaPrescription onlyLaboratorios Cinfa S.A.90106
MIRABEGRON NORMON50 mg · comprimido de liberación prolongadaPrescription onlyLaboratorios Normon S.A.89487

3 more names not shown. Source: CIMA — Centro de Información online de Medicamentos (Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)) · 2026-09-30 · Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA.

Canada 4 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
APO-MIRABEGRON50 mg · tablet (extended-release)Prescription onlyApotex Inc02564971
AURO-MIRABEGRON50 mg · tablet (extended-release)Prescription onlyAuro Pharma Inc02564955
MYRBETRIQ50 mg · tablet (extended-release)Prescription onlyAstellas Pharma Canada Inc02402882
SANDOZ MIRABEGRON50 mg · tablet (extended-release)Prescription onlySandoz Canada Incorporated02558483

Source: Drug Product Database (Health Canada) · 2026-09-30 · Contains information licensed under the Open Government Licence – Canada.

Netherlands 5 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
Betmiga 50 mg50 mg · tablet met verlengde afgiftePrescription onlyAstellas Pharma Europe B.V.EU/1/12/809
Mirabegron CF 50 mg50 mg · tablet met verlengde afgiftePrescription onlyCentrafarm B.V.132792
Mirabegron Glenmark 50 mg50 mg · tablet met verlengde afgiftePrescription onlyGlenmark Arzneimittel GmbH131891
Mirabegron Teva 50 mg50 mg · tablet met verlengde afgiftePrescription onlyTeva Nederland B.V.132822
Mirabegron Zentiva 50 mg50 mg · tablet met verlengde afgiftePrescription onlyZentiva k.s.131882

Source: Geneesmiddeleninformatiebank (College ter Beoordeling van Geneesmiddelen (CBG-MEB)) · 2026-09-30 · Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site.

Same active substance, but no match for this strength and form

Countries covered: United States, Bulgaria, European Union, Spain, France, Netherlands, Canada, Switzerland. A country missing from the list may still sell this medicine: Mediclarum reads only these registers.

Register data as of 2026-08-01. Mediclarum stores nothing about you for this page. https://www.mediclarum.com/bg/en/medicines/miragron-50-mg-prolonged-release-tablets